Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA DIVIS LABORATORIES AJANTA PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 38.3 66.0 58.1% View Chart
P/BV x 8.3 7.1 116.4% View Chart
Dividend Yield % 0.3 0.9 35.8%  

Financials

 AJANTA PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
DIVIS LABORATORIES
Mar-23
AJANTA PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,4264,641 30.7%   
Low Rs1,0622,730 38.9%   
Sales per share (Unadj.) Rs297.2292.6 101.6%  
Earnings per share (Unadj.) Rs46.768.7 68.0%  
Cash flow per share (Unadj.) Rs57.181.6 69.9%  
Dividends per share (Unadj.) Rs7.0030.00 23.3%  
Avg Dividend yield %0.60.8 69.1%  
Book value per share (Unadj.) Rs269.1480.9 55.9%  
Shares outstanding (eoy) m125.91265.47 47.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.212.6 33.2%   
Avg P/E ratio x26.653.7 49.6%  
P/CF ratio (eoy) x21.845.2 48.3%  
Price / Book Value ratio x4.67.7 60.3%  
Dividend payout %15.043.7 34.3%   
Avg Mkt Cap Rs m156,638978,378 16.0%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8519,750 80.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42677,675 48.2%  
Other income Rs m9863,447 28.6%   
Total revenues Rs m38,41381,122 47.4%   
Gross profit Rs m7,83323,691 33.1%  
Depreciation Rs m1,3083,432 38.1%   
Interest Rs m5820 298.0%   
Profit before tax Rs m7,45323,686 31.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5735,453 28.8%   
Profit after tax Rs m5,88018,234 32.2%  
Gross profit margin %20.930.5 68.6%  
Effective tax rate %21.123.0 91.7%   
Net profit margin %15.723.5 66.9%  
BALANCE SHEET DATA
Current assets Rs m28,25297,437 29.0%   
Current liabilities Rs m11,39315,331 74.3%   
Net working cap to sales %45.0105.7 42.6%  
Current ratio x2.56.4 39.0%  
Inventory Days Days668 785.7%  
Debtors Days Days10842 1.2%  
Net fixed assets Rs m18,70751,128 36.6%   
Share capital Rs m253531 47.6%   
"Free" reserves Rs m33,624127,140 26.4%   
Net worth Rs m33,877127,671 26.5%   
Long term debt Rs m130-   
Total assets Rs m47,047148,565 31.7%  
Interest coverage x128.61,209.5 10.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 152.2%   
Return on assets %12.612.3 102.7%  
Return on equity %17.414.3 121.5%  
Return on capital %22.218.6 119.4%  
Exports to sales %59.985.7 69.9%   
Imports to sales %11.519.8 57.9%   
Exports (fob) Rs m22,42066,537 33.7%   
Imports (cif) Rs m4,29315,378 27.9%   
Fx inflow Rs m22,42066,537 33.7%   
Fx outflow Rs m4,29315,715 27.3%   
Net fx Rs m18,12750,822 35.7%   
CASH FLOW
From Operations Rs m7,91824,597 32.2%  
From Investments Rs m-5,596-27,076 20.7%  
From Financial Activity Rs m-1,079-7,972 13.5%  
Net Cashflow Rs m1,243-10,451 -11.9%  

Share Holding

Indian Promoters % 66.2 51.9 127.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 36.7 70.2%  
FIIs % 9.1 14.9 61.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 48.1 70.3%  
Shareholders   54,351 354,482 15.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on AJANTA PHARMA vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Divis Laboratories Share Price Performance

Period AJANTA PHARMA Divis Laboratories S&P BSE HEALTHCARE
1-Day 2.51% 2.14% 1.18%
1-Month 7.60% -2.15% -0.75%
1-Year 92.91% 22.51% 61.82%
3-Year CAGR 21.63% -1.38% 18.16%
5-Year CAGR 26.85% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.